This content is only available within our institutional offering.
30 Mar 2023
A year of achievement
Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
A year of achievement
Poolbeg Pharma PLC (POLB:LON) | 3.9 0 11.4% | Mkt Cap: 27.2m
- Published:
30 Mar 2023 -
Author:
Karl Keegan -
Pages:
3 -
POLB had a tremendous 2022 despite the difficult market backdrop and the start to 2023 has shown further progress,with the stock up 32% YTD.. The management team delivered on the promises of the IPO, building up the portfolio in a capital light manner and gaining significant non-dilutive funding through the award of a grant to a consortium led by POLB. We maintain our BUY recommendation and increase our P/T to 21p (from 20p).